quinoxalines has been researched along with Malaria in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ospina-Villa, JD; Soto-Sánchez, J | 1 |
| Aldana, I; Beltrán-Hortelano, I; Bonilla-Ramirez, L; Bordessoulles, M; Corcuera, L; Franetich, JF; Galiano, S; López de Cerain, A; Mazier, D; Pabón, A; Quiliano, M; Ramirez-Calderon, G; Rios, A; Vettorazzi, A | 1 |
| Bodenreider, C; Bursulaya, B; Chatterjee, AK; Dechering, KJ; Diagana, TT; Fidock, DA; Fischli, C; Gagaring, K; Glynne, RJ; Haasen, D; Henrich, PP; Ibanez, M; Kato, N; Kocken, CH; Kuhen, KL; Kumar, TS; Lee, MC; Lim, CS; Lim, SH; Manary, MJ; McCormack, SL; McNamara, CW; Meister, S; Nagle, A; Nosten, F; Plouffe, DM; Rameh, L; Renia, L; Roland, J; Rottmann, M; Russell, B; Sauerwein, RW; Simon, O; Suwanarusk, R; Timmerman, M; Trappe, J; Tully, DC; Winzeler, EA; Yeung, BK; Zeeman, AM | 1 |
| Castro, EA; Duchowicz, PR; Monge, A; Ortiz, Edel V; Vicente, E | 1 |
| Arán, VJ; Malagón, F; Martínez, C; Ponce, YM; Rivera, N | 1 |
| Aldana, I; Deharo, E; Jaso, A; Jullian, V; Maurel, S; Monge, A; Sauvain, M; Zarranz, B | 1 |
| Gupta, CN; Parimoo, P; Prasad, AL; Rangisetty, JB; Sridhar, N; Srinivas, P; Veeranjaneyulu, A | 1 |
| Djudovic, P; Maier, W; Piekarski, G; Schornstein, U; Zymalkowski, F | 1 |
| Fisher, GH; Moreno, HR; Oatis, JE; Schultz, HP | 1 |
| Folkers, K; Porter, TH; von Klaudy, A | 1 |
| Moreno, HR; Oatis, JE; Schultz, HP | 1 |
1 review(s) available for quinoxalines and Malaria
| Article | Year |
|---|---|
Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
Topics: Animals; Antiparasitic Agents; Benzene; Chagas Disease; Humans; Leishmaniasis; Malaria; Oxidation-Reduction; Oxides; Pyrazines; Quinoxalines; Structure-Activity Relationship | 2021 |
11 other study(ies) available for quinoxalines and Malaria
| Article | Year |
|---|---|
Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Topics: Animals; Antimalarials; Chloroquine; Female; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Mice, Inbred BALB C; Plasmodium; Primaquine; Quinoxalines | 2018 |
Public health round-up.
Topics: Adenosine Monophosphate; Alanine; Aminoisobutyric Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Benzimidazoles; Cyclopropanes; Democratic Republic of the Congo; Disease Outbreaks; Drug Resistance, Bacterial; Global Health; Hemorrhagic Fever, Ebola; Hepatitis C; Humans; Interinstitutional Relations; Lactams, Macrocyclic; Leucine; Malaria; Measles; Measles Vaccine; Poliomyelitis; Proline; Public Health Practice; Pyrrolidines; Quinoxalines; Randomized Controlled Trials as Topic; Ribonucleotides; Sulfonamides; Tuberculosis | 2019 |
Targeting Plasmodium PI(4)K to eliminate malaria.
Topics: 1-Phosphatidylinositol 4-Kinase; Adenosine Triphosphate; Animals; Binding Sites; Cytokinesis; Drug Resistance; Fatty Acids; Female; Hepatocytes; Humans; Imidazoles; Life Cycle Stages; Macaca mulatta; Malaria; Male; Models, Biological; Models, Molecular; Phosphatidylinositol Phosphates; Plasmodium; Pyrazoles; Quinoxalines; rab GTP-Binding Proteins; Reproducibility of Results; Schizonts | 2013 |
Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
Topics: Antimalarials; Antitubercular Agents; Humans; Linear Models; Malaria; Models, Biological; Mycobacterium tuberculosis; Oxides; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quinoxalines; Tuberculosis | 2010 |
Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii.
Topics: Administration, Oral; Animals; Antimalarials; Biological Assay; Disease Models, Animal; Malaria; Male; Mice; Plasmodium yoelii; Quinoxalines; Survival Analysis; Treatment Outcome | 2013 |
Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
Topics: Animals; Antimalarials; Cell Line, Tumor; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Erythrocytes; Female; Hemin; In Vitro Techniques; Indicators and Reagents; Magnetic Resonance Spectroscopy; Malaria; Mice; Nitriles; Plasmodium berghei; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2005 |
Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice.
Topics: Animals; Antimalarials; Chloroquine; Indicators and Reagents; Malaria; Mannich Bases; Mice; Plasmodium yoelii; Quinoxalines | 2001 |
[Synthesis of quinoline-3- and quinoxaline-2- derivatives and their actions against various malarial parasites].
Topics: Animals; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Malaria; Mice; Plasmodium; Plasmodium berghei; Quinolines; Quinoxalines | 1976 |
Quinoxaline studies. 23. Potential antimalarials. Substituted 5,8-dimethoxyquinoxalines.
Topics: Animals; Antimalarials; Chickens; Malaria; Malaria, Avian; Mice; Plasmodium berghei; Quinoxalines; Spectrophotometry, Ultraviolet | 1975 |
Antimetabolites of coenzyme Q. 20. Synthesis of new alkyl-5,8-quinoxalinequinones as potential inhibitors of coenzyme Q and as antimalarial drugs.
Topics: Animals; Antimalarials; Antimetabolites; Chickens; In Vitro Techniques; Malaria; Mice; Mitochondria; NADH, NADPH Oxidoreductases; Plasmodium berghei; Quinones; Quinoxalines; Succinate Dehydrogenase; Ubiquinone | 1973 |
Quinoxaline studies. 20. Potential antimalarials. Synthesis of anti- and syn-N,N-dialkylaminomethyl 2-quinoxalinyl ketoximes.
Topics: Animals; Antimalarials; Magnetic Resonance Spectroscopy; Malaria; Methylamines; Mice; Oximes; Quinoxalines; Spectrum Analysis; Stereoisomerism; Ultraviolet Rays | 1972 |